Nepal Cervical Cancer Screening and Treatment Pilot project
Description
Objective: Eensure effectiveness of thermo coagulation therapy piloting test for treatment of CC
Methodology <br />
<br />
1. Study Areas:<br />
<br />
Two districts with high disadvantage (Tamang, Magar, etc) population selected for piloting. Kavre district has 93 health facilities with 580 aged 30-60 population. Similarly Sindhupalchowk has 78 health facilities with average 512 aged 30-60 women population.<br />
<br />
Description Kavre Dist Sindhu Dist<br />
1) Health Facilities 93 78<br />
2) Estimated 30-60 women population for screening 54000 40000<br />
3) Average number of pop per facilities 580 512<br />
4) Estimated days for the camp - 100 women - screen/treatment 6 5<br />
5) Total days for camp (for one group) (including travel days 651 468<br />
6) Total days for camp (for two group) 325.5 234<br />
<br />
Research design: A cross sectional pilot study will be conducted in order to evaluate acceptability, efficacy, safety and adverse events. Based on findings scale up protocol will be developed for the scaling up the intervention.<br />
<br />
Research Participant: The research participants will be all women aged 30-60 years old of particular study areas. <br />
<br />
Sample size: Census of women aged 30-60 years old.<br />
<br />
Study Duration: 5 years (from 2019 – 2024)<br />
<br />
Inclusion: All women of aged 30 – 60 years devoid of their marital status.<br />
<br />
Exclusion: The program exclude below 30 years old women. The program will also exclude the women who already removed uterus.<br />
Training
One day orientation and planning meeting will be held for the health post incharges, palika coordinator and mayor and deputy mayor. After completion of program orientation, a planning meeting will be held to fix date for camp in the particular health post. The training will be led by Family Welfare Division and Lifeline Nepal technical staff. <br />
<br />
Pre-testing of data collection tools <br />
Two day training will be provided to data collectors on the data collection tools. <br />
A dumy camp will be organized in a particular health facility to pre-test tool. <br />
<br />
Organization of camp – A cervical cancer screening camp in each health facility will be organized inviting all 30-60 years women to attend camps. During the camps, background information, VA screening, diagnosis and treatment recorded in the TAB. Further more, photo before and after diagnose will taken.<br />
<br />
Data Analysis – Data will be analyzed using framework analysis approach covering acceptability, efficacy, safety and adverse effects. Furthermore health workers perception of device acceptances<br />
<br />
Ethical approval – This protocol will be submitted to the relevant Nepal Health Research Council.<br />
<br />
Written informed consent of all women 30 – 60 years of age will be obtained after the completion cervical cancer screening and treatment.
Approach for Coordination at different level<br />
HEAL Group will make every effort to synchronize and integrate all activities of the study. Responsibilities, command and internal control structures will be established to ensure that the resources are used most effectively and efficiently. <br />
HEAL Group will monitor the field level activity in each month throughout the project. To conduct the joint monitoring with Nepal Health Research Council and Family Welfare Division will be requested for assuring the quality of project activities.<br />
<br />
International Level <br />
University of Utah will be responsible to coordinate with International level and other potential donors. <br />
<br />
Central Level<br />
The Office Manager will be responsible to coordinate with Government at the central level and INGOs. The Project Manager will periodically call the meeting inviting Nepal Health Research Council and Family Welfare Division> <br />
<br />
Province Level<br />
Program Coordinator will be responsible in coordinating study related activities at the Provinces and Local Government. Prior to implement the study at the HFs and community level, they will hold preliminary inception meeting with concerned officials of Provinces. They will assist the Provinces to circulate letters to concerned HFs through local government (Palikas) on the study. Site Coordinator/Training Coordinator will also periodically update the Palikas and provinces on data collection regarding the acceptability study.
SDGS & Targets
Goal 5
Achieve gender equality and empower all women and girls
5.1
End all forms of discrimination against all women and girls everywhere
5.1.1
Whether or not legal frameworks are in place to promote, enforce and monitor equality and non‑discrimination on the basis of sex
5.2
5.2.1
Proportion of ever-partnered women and girls aged 15 years and older subjected to physical, sexual or psychological violence by a current or former intimate partner in the previous 12 months, by form of violence and by age
5.2.2
Proportion of women and girls aged 15 years and older subjected to sexual violence by persons other than an intimate partner in the previous 12 months, by age and place of occurrence
5.3
5.3.1
Proportion of women aged 20-24 years who were married or in a union before age 15 and before age 18
5.3.2
Proportion of girls and women aged 15-49 years who have undergone female genital mutilation/cutting, by age
5.4
Recognize and value unpaid care and domestic work through the provision of public services, infrastructure and social protection policies and the promotion of shared responsibility within the household and the family as nationally appropriate
5.4.1
Proportion of time spent on unpaid domestic and care work, by sex, age and location
5.5
Ensure women’s full and effective participation and equal opportunities for leadership at all levels of decision-making in political, economic and public life
5.5.1
Proportion of seats held by women in (a) national parliaments and (b) local governments
5.5.2
Proportion of women in managerial positions
5.6
Ensure universal access to sexual and reproductive health and reproductive rights as agreed in accordance with the Programme of Action of the International Conference on Population and Development and the Beijing Platform for Action and the outcome documents of their review conferences
5.6.1
Proportion of women aged 15-49 years who make their own informed decisions regarding sexual relations, contraceptive use and reproductive health care
5.6.2
Number of countries with laws and regulations that guarantee full and equal access to women and men aged 15 years and older to sexual and reproductive health care, information and education
5.a
Undertake reforms to give women equal rights to economic resources, as well as access to ownership and control over land and other forms of property, financial services, inheritance and natural resources, in accordance with national laws
5.a.1
(a) Proportion of total agricultural population with ownership or secure rights over agricultural land, by sex; and (b) share of women among owners or rights-bearers of agricultural land, by type of tenure
5.a.2
Proportion of countries where the legal framework (including customary law) guarantees women’s equal rights to land ownership and/or control
5.b
5.b.1
Proportion of individuals who own a mobile telephone, by sex
5.c
Adopt and strengthen sound policies and enforceable legislation for the promotion of gender equality and the empowerment of all women and girls at all levels
5.c.1
Proportion of countries with systems to track and make public allocations for gender equality and women’s empowerment
Goal 3
Ensure healthy lives and promote well-being for all at all ages
3.1
3.1.1
Maternal mortality ratio
3.1.2
Proportion of births attended by skilled health personnel
3.2
3.2.1
Under-five mortality rate
3.2.2
Neonatal mortality rate
3.3
By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases
3.3.1
Number of new HIV infections per 1,000 uninfected population, by sex, age and key populations
3.3.2
Tuberculosis incidence per 100,000 population
3.3.3
Malaria incidence per 1,000 population
3.3.4
Hepatitis B incidence per 100,000 population
3.3.5
Number of people requiring interventions against neglected tropical diseases
3.4
3.4.1
Mortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory disease
3.4.2
Suicide mortality rate
3.5
Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol
3.5.1
Coverage of treatment interventions (pharmacological, psychosocial and rehabilitation and aftercare services) for substance use disorders
3.5.2
Alcohol per capita consumption (aged 15 years and older) within a calendar year in litres of pure alcohol
3.6
3.6.1
Death rate due to road traffic injuries
3.7
By 2030, ensure universal access to sexual and reproductive health-care services, including for family planning, information and education, and the integration of reproductive health into national strategies and programmes
3.7.1
Proportion of women of reproductive age (aged 15-49 years) who have their need for family planning satisfied with modern methods
3.7.2
Adolescent birth rate (aged 10-14 years; aged 15-19 years) per 1,000 women in that age group
3.8
Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all
3.8.1
Coverage of essential health services
3.8.2
Proportion of population with large household expenditures on health as a share of total household expenditure or income
3.9
3.9.1
Mortality rate attributed to household and ambient air pollution
3.9.2
Mortality rate attributed to unsafe water, unsafe sanitation and lack of hygiene (exposure to unsafe Water, Sanitation and Hygiene for All (WASH) services)
3.9.3
Mortality rate attributed to unintentional poisoning
3.a
3.a.1
Age-standardized prevalence of current tobacco use among persons aged 15 years and older
3.b
Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all
3.b.1
Proportion of the target population covered by all vaccines included in their national programme
3.b.2
3.b.3
Proportion of health facilities that have a core set of relevant essential medicines available and affordable on a sustainable basis
3.c
3.c.1
Health worker density and distribution
3.d
Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks
3.d.1
International Health Regulations (IHR) capacity and health emergency preparedness
3.d.2
Percentage of bloodstream infections due to selected antimicrobial-resistant organisms
SDG 14 targets covered
| Name | Description |
|---|
Deliverables & Timeline
Resources mobilized
Partnership Progress
Feedback
Share
Timeline
Entity
Geographical coverage
More information
Countries
Contact Information
Sushil Karki, CEO